PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
116 hedge funds and large institutions have $419M invested in Paratek Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
57% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 28
59% less call options, than puts
Call options by funds: $1.12M | Put options by funds: $2.75M
Holders
116
Holding in Top 10
2
Calls
$1.12M
Puts
$2.75M
Top Buyers
| 1 | +$4M | |
| 2 | +$3.22M | |
| 3 | +$2.54M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$2.26M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.72M |
Top Sellers
| 1 | -$9.04M | |
| 2 | -$6.08M | |
| 3 | -$5.29M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$5.29M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.83M |